Dr. Naureen Starling
Company: The Royal Marsden NHS Foundation Trust
Job title: Consultant Medical Oncologist
Seminars:
Panel Discussion & Q&A: Emergence of Novel Clinical Biomarkers- Molecular Response, Methylation, MRD 2:55 pm
The objective of this session is to expound on the field of novel predictive and prognostic biomarkers that would aid in the identification of late-stage cancer patients who would respond to the ever-growing repertoire of therapies that includes next-generation immunotherapies, epigenetic modulators, and bi-specific antibodies. The panel will discuss the current and future state of…Read more
day: Guardant Health Afternoon Workshop
Panel Discussion & Q&A: Clinical Implication of Minimally Residual Disease (MRD) Diagnostics 1:35 pm
The objective of this session is to review and discuss the latest trends in Minimal Residual Disease (MRD) for the solid tumor space, focusing on key disease indications and the clinical data necessary for regulatory approval and healthcare provider adoption. Our panel will discuss the breadth of existing MRD data, the unmet clinical needs, and…Read more
day: Guardant Health Afternoon Workshop
Introduction to Minimally Residual Disease (MRD) Detection in CRC Patients 1:20 pm
day: Guardant Health Afternoon Workshop